Showing results (31-40 of 625) with videos related to

Sort By:
Pageof 63
F1000Prime Reports|June 23, 2015
Recent advances in understanding and managing leiomyosarcomasFlorence Duffaud, Isabelle Ray-Coquard, Sébastien Salas, et al.
Current Opinion in Obstetrics & Gynecology|December 10, 2014
New clinical research strategies for rare gynecologic malignanciesIsabelle Ray-Coquard, Eric Pujade-Lauraine, Jonathan A Ledermann
Bulletin Du Cancer|March 2, 2023
[Homologous recombination deficiency in epithelial ovarian cancers: from molecular characterization to patient journey]Stanislas Quesada, Jérôme Solassol, Isabelle Ray-Coquard, et al.
Seminars in Cancer Biology|September 15, 2020
Challenges for immunotherapy for the treatment of platinum resistant ovarian cancerOlivia Le Saux, Isabelle Ray-Coquard, S Intidhar Labidi-Galy
Bulletin Du Cancer|September 13, 2007
[Angiogenesis and breast cancer]Thomas Bachelot, Isabelle Ray-Coquard, Philippe Cassier, et al.
Current Oncology Reports|August 16, 2014
High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approachesCharles-André Philip, Patricia Pautier, Florence Duffaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Soft Tissue and Uterine LeiomyosarcomaSuzanne George, César Serrano, Martee L Hensley, et al.
The Lancet. Haematology|December 21, 2020
Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance databasePierre-Marie Morice, Alexandra Leary, Charles Dolladille, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2025
Controversies in the organization and structure of management for rare tumorsIsabelle Ray-Coquard, Jonathan Ledermann, Anna DeFazio, et al.
Journal for Immunotherapy of Cancer|March 30, 2019
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, et al.
Pageof 63